Yatsen combines strong product-level economics, especially in skincare, with a robust balance sheet and a well-developed innovation platform. Its high gross margins, net cash position, and ample liquidity provide breathing room to pursue its strategic shift. The company’s digital-native capabilities, multi-brand portfolio, and deepening R&D footprint position it well within the growing C-beauty and premium skincare segments. Recent quarterly signs of revenue growth and a return to profitability suggest that the strategic pivot is beginning to gain traction, at least in the short term.

The biggest concerns are persistent operating losses, negative cash flow from operations, and a very heavy SG&A cost base that has yet to be right-sized relative to revenue. Accumulated historical losses are large, and the business still relies on drawing down cash and selling investments to offset cash burn. Competitive intensity, dependence on major online platforms, and the execution risk of offline expansion all add to uncertainty. The high proportion of goodwill and other intangibles also raises the risk of future asset write-downs if certain brands or acquisitions do not perform as expected.

Yatsen appears to be in the middle of a multi-year transition from a fast-growing, marketing-heavy brand to a more balanced, R&D-driven beauty group anchored in skincare. The ingredients for success—strong gross margins, scientific capabilities, brand assets, and a solid balance sheet—are present, but the financial statements still reflect a business that has not fully converted these strengths into sustainable profitability and positive free cash flow. The forward-looking picture will depend on whether the company can maintain revenue and skincare growth while structurally improving cost efficiency and cash generation; both upside and downside scenarios remain plausible given the current mix of strengths and risks.